LONDON--(BUSINESS WIRE)--The active pharmaceutical ingredients market is poised to grow by USD 60.56 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Request free sample pages
Read the 156-page report with TOC on "Active Pharmaceutical Ingredients Market Analysis Report by Type (Captive API and Contract API) and Geographic Landscape (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020-2024".Show Full Article
Are you looking for VA's? Want to hire a Virtual Assistant? You're just one step away. Our system will help you get the right Assistant for your Business. It's easy and relaible way of getting connected with an Assistant. Register Now.
- or -
Are you an Assistant? Want to offer your service virtually? Register as a Company and get connected to clients.
The Virtual List process is Simple! Want to know how?
Simply register and post your task sample as requirement on Request Quote tab, when you are looking to hire a Virtual Assistant Company.
And, when you are offering your VA services. Register and Send Quotes on the submitted request. It is just that simple. Prospects will review your proposal and get in touch directly.
Disclaimer: We do not charge any type of commission or fees for the service.
Our service is Free.
The market is driven by the increasing number of type II DMFs. In addition, the paradigm shift in API manufacturing is anticipated to boost the growth of the active pharmaceutical ingredients market.
DMF helps in providing detailed information about the facilities, processes, and materials used in the manufacturing, processing, and packaging of drugs intended for human use. Among the five types of DMFs, type II DMF drug is the most common form and covers drug substances, substance intermediates, and materials used in the penetration of the drug product. Therefore, API manufacturers have been leveraging the increased outsourcing demand for APIs or intermediates, which is reflected through the aggressive DMF filings. Increasing investments to enhance manufacturing facilities by Asian companies to meet international quality standards have also contributed to the rise in the number of DMF filings over the past two decade. In addition, market players in India are increasingly focusing on achieving compliance with standards laid by various regulatory agencies such as the US FDA, TGA, MHRA, Brazilian Health Regulatory Agency, and SAHPRA. The increasing DMF approvals by regulatory agencies are providing significant growth opportunities for API manufacturers. These factors are fueling the growth of the global active pharmaceutical ingredients market.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Active Pharmaceutical Ingredients Companies:
Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. Operates the business across segments such as Generics and Specialty. The company performs captive manufacturing of APIs for its own finished pharmaceutical products.
Cadila Healthcare Ltd.
Cadila Healthcare Ltd. Operates the business in the Pharmaceuticals segment. The company offers 38 APIs and intermediates across various therapeutic categories.
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc operates its business through a unified business segment. The company offers a wide range of APIs used for the manufacture of various finished pharmaceutical products.
Lupin Ltd. Operates the business through the Pharmaceuticals segment. The segment focuses on the discovery, development, manufacture, and commercialization of finished pharmaceutical products and APIs. The company offers a wide range of APIs used for the manufacture of various finished pharmaceutical products.
Mylan NV operates the business across segments such as Gx, Rx/Bx, and OTC. The company offers a wide range of APIs used for the manufacture of various finished pharmaceutical products across various therapeutic areas, such as HIV/AIDS, antibacterials, central nervous system agents, antihistamines/anti-asthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors.
Register for a free trial today and gain instant access to 17,000+ market research reports
Technavio's SUBSCRIPTION platform
Active Pharmaceutical Ingredients Market Type Outlook (Revenue, USD Billion, 2020-2024)
Active Pharmaceutical Ingredients Market Geographic Landscape Outlook (Revenue, USD Billion, 2020-2024)
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Thank you for your valuable time considering TheVirtualList.com as your Virtual Assistant Community Forum. The team has curated more valuable news on "Global Active Pharmaceutical Ingredients Market 2020-2024 | Evolving Opportunities With Amneal Pharmaceuticals Inc. And Cadila Healthcare Ltd. | Techn". Are you excited and wanna learn more! Excellent here are more articles on Business Outsourcing Ltd.